| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/05/2009 | WO2009016449A1 Antibody purification process by precipitation |
| 02/05/2009 | WO2009016164A1 Novel antibodies |
| 02/05/2009 | WO2009016100A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 02/05/2009 | WO2009015908A2 Anti ephb4 antibodies and antibody fragments |
| 02/05/2009 | WO2009015696A1 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest |
| 02/05/2009 | WO2008147196A3 Rsv-specific binding molecules and means for producing them |
| 02/05/2009 | WO2008145133A3 Method for manufacturing a recombinant polyclonal protein |
| 02/05/2009 | WO2008140602A3 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 02/05/2009 | WO2008131376A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 02/05/2009 | WO2008130381A3 Polyglutamic acid compositions and their use as immunogens |
| 02/05/2009 | WO2008125623A3 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9) |
| 02/05/2009 | WO2008122886A3 Transgenic non-human mammal with homodimeric vh binding complex |
| 02/05/2009 | WO2008122551A9 Anti-epcam antibody and uses thereof |
| 02/05/2009 | WO2008054606A3 High affinity human antibodies to human il-4 receptor |
| 02/05/2009 | WO2008047242A9 Novel anti-cd38 antibodies for the treatment of cancer |
| 02/05/2009 | WO2008036341A3 Compositions and methods relating to glucagon receptor antibodies |
| 02/05/2009 | US20090038023 Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| 02/05/2009 | US20090036653 Methods for the directed expansion of epitopes for use as antibody ligands |
| 02/05/2009 | US20090036537 Aromatic triamide-lanthanide complexes |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036398 Human G-Protein Coupled Receptor (HETGQ23) |
| 02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
| 02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 02/05/2009 | US20090036363 Peptides as cell penetrating carriers |
| 02/05/2009 | US20090036362 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof |
| 02/05/2009 | US20090036318 Class II Human Histone Deacteylases, and Uses Related Thereto |
| 02/05/2009 | US20090035875 Cytochrome C And Leucine-Rich Alpha-2-Glycoprotein-1 Assays, Methods, And Antibodies |
| 02/05/2009 | US20090035849 Depletion of plasma proteins |
| 02/05/2009 | US20090035836 Modulating ph-sensitive binding using non-natural amino acids |
| 02/05/2009 | US20090035819 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/05/2009 | US20090035818 Novel Polypeptide, Polynucleotide Encoding the Polypeptide and Use the Polypeptide and Polynucleotide |
| 02/05/2009 | US20090035799 Novel trypsin family serine proteases |
| 02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
| 02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
| 02/05/2009 | US20090035322 Human Antibodies to Human CD20 and Method of Using Thereof |
| 02/05/2009 | US20090035321 Intercellular adhesion molecules and their binding ligands |
| 02/05/2009 | US20090035320 Agents for Regulating Liver Regeneration/Repair |
| 02/05/2009 | US20090035319 Antibodies Against C3a Receptor |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
| 02/05/2009 | US20090035308 Methods for using and identifying modulators of Delta-like 4 |
| 02/05/2009 | US20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 02/05/2009 | US20090035299 Methods and compositions for treating diseases targeting MABA1 |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035295 Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090035217 Truncated Fragments of Alpha-Synuclein in Lewy Body Disease |
| 02/05/2009 | CA2695399A1 Multimeric multiepitope influenza vaccines |
| 02/05/2009 | CA2695382A1 A fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 02/05/2009 | CA2695199A1 Human antibodies to human cd20 and method of using thereof |
| 02/05/2009 | CA2694644A1 Pharmaceutical combinations |
| 02/05/2009 | CA2694488A1 Multispecific epitope binding proteins and uses thereof |
| 02/05/2009 | CA2694363A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 02/05/2009 | CA2694055A1 Novel antibodies |
| 02/05/2009 | CA2694034A1 Antibody purification process by precipitation |
| 02/05/2009 | CA2689024A1 High sensitivity immunoassays and kits for the determination of peptidesand proteins of biological interest |
| 02/04/2009 | EP2020604A1 Ligand for G-protein coupled receptor FPRL2 and uses thereof |
| 02/04/2009 | EP2020602A1 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest |
| 02/04/2009 | EP2020445A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/04/2009 | EP2020419A1 Anti ephB4 antibody fragments |
| 02/04/2009 | EP2020417A1 Prostasin partial peptide and anti-prostasin antibody |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019842A2 Immunosuppressant binding antibodies and methods of obtaining and using same |
| 02/04/2009 | EP2019841A2 Antagonist anti-cd40 antibody pharmaceutical compositions |
| 02/04/2009 | EP2019840A2 Antagonistic anti-human cd40 monoclonal antibody |
| 02/04/2009 | CN101360999A Intraocular pressure-regulated early genes and uses thereof |
| 02/04/2009 | CN101360761A Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use |
| 02/04/2009 | CN101360760A Biological materials and uses thereof |
| 02/04/2009 | CN101360758A Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/04/2009 | CN101360512A Food products comprising probiotic micro-organisms and antibodies |
| 02/04/2009 | CN101357944A Anti-idio-typic antibody NP30 chimeric Fab fragment of japonicum, preparation method and application |
| 02/04/2009 | CN101357943A Glycoprotein compositions |
| 02/04/2009 | CN101357942A Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
| 02/04/2009 | CN101357941A Heat resistant bovine colostrum immunoglobulin and preparation method |
| 02/04/2009 | CN101357230A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/04/2009 | CN100457908C Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 02/04/2009 | CN100457907C Recombinant helicobacter pylori outer-membrane protein 15 |
| 02/04/2009 | CN100457903C New type Japanese schistosome dominant antigen molecule |
| 02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/04/2009 | CN100457895C Mouse anti-human macrophage migration inhibiting factor monoclonal antibody and its application |
| 02/04/2009 | CN100457781C Antibodies against cancer |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/03/2009 | US7485773 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 02/03/2009 | US7485704 Reducing protein A leaching during protein A affinity chromatography |
| 02/03/2009 | US7485703 Antibody against G-protein coupled receptor showing selective affinity for ATP and uses therefor |
| 02/03/2009 | US7485700 Interferon-like protein ZCYTO21 |
| 02/03/2009 | US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 02/03/2009 | US7485459 Human neuronal attachment factor-1 antibodies |
| 02/03/2009 | US7485431 Antibody or antigen-binding fragment that binds to a polypeptide; gene family containing which contain SCUBE proteins which can be expressed in endothelial cells; cardiovascular, bone, breast, and metabolic disorders; antiinflammatory and anticoagulant agents; antiischemic agents, atherosclerosis |
| 02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
| 02/03/2009 | US7485312 Surface protein (HBsAg) variant of the hepatitis B virus |
| 02/03/2009 | US7485305 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering |
| 02/03/2009 | US7485303 Pharmaceutical composition of F(ab')2 antibody fragments |
| 02/03/2009 | US7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |